---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-031828"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2025-08-19T23:59:59+00:00"
generated_at: "2026-05-17T11:25:46.352938+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Nuwellis enters non-binding LOI to acquire Rendiatech, an Israeli renal monitoring firm

## Summary
- Rendiatech specializes in real-time urine flow and acute kidney injury monitoring technologies.
- Acquisition intended to expand Nuwellis' platform beyond ultrafiltration into continuous renal health monitoring.
- Parties in due diligence; transaction expected to close in Q4 2025, pending board approval and conditions.
- No financial terms disclosed in the non-binding letter of intent.

## SEC filing metadata
- accession: 0001140361-25-031828
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2025-08-19T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036125031828/0001140361-25-031828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036125031828/ef20054176_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-031828
- JSON: https://secwatch.observer/filing/0001140361-25-031828.json
- Plain text: https://secwatch.observer/filing/0001140361-25-031828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.